West Pharmaceutical Services revenue and financials
In the fiscal year ended December 2025, West Pharmaceutical Services reported revenue of $3.07B (+6.25% year over year). Net income was $493.7M, a net margin of 16.1%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +6.25%
- 2025 vs 2024
- Net income growth
- +0.20%
- 2025 vs 2024
- Net margin
- 16.1%
- 2024: 17.0%
How West Pharmaceutical Services is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 7.4% a year on average over the last 5 years
Compound annual growth rate: from $2.15B in 2020 to $3.07B in 2025.
Operating margin fell from 25.4% to 19.0%
Operating income over revenue, 2022 → 2025: 6.4 percentage points.
Free cash flow equal to 73% of net income
Totals for fiscal years 2023–2025: free cash flow $1.16B, net income $1.58B.
Shares outstanding down 4.1% in 5 years
Average diluted shares, 2020 → 2025: with fewer shares, each one represents a larger stake in the company.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3,074 | 2,893 | 2,950 | 2,887 | 2,832 | 2,147 | 1,840 | 1,717 | 1,599 | 1,509 |
| Cost of revenue | 1,970 | 1,895 | 1,821 | 1,751 | 1,656 | 1,379 | 1,234 | 1,172 | 1,086 | 1,008 |
| Gross profit | 1,104 | 999 | 1,129 | 1,136 | 1,176 | 768 | 606 | 545 | 513 | 501 |
| Selling, general and administrative | 390 | 335 | 354 | 316 | 356 | 301 | 273 | 256 | 243 | 238 |
| Research and development | 74.3 | 69.1 | 68.4 | 58.5 | 52.8 | 46.9 | 38.9 | 40.3 | 39.1 | 36.8 |
| Operating income | 585 | 570 | 676 | 734 | 752 | 407 | 297 | 240 | 226 | 195 |
| EBIT | 639 | 594 | 706 | 764 | 769 | 423 | 296 | 251 | 239 | 229 |
| EBITDA | 810 | 749 | 844 | 884 | 891 | 532 | 399 | 355 | 336 | 320 |
| Interest expense | 0.5 | 3.0 | 9.0 | 7.9 | 8.2 | 8.2 | 8.5 | 8.4 | 7.8 | 8.1 |
| Pre-tax income | 615 | 600 | 716 | 701 | 769 | 419 | 301 | 248 | 232 | 198 |
| Income tax | 122 | 108 | 122 | 115 | 107 | 72.5 | 59.0 | 41.4 | 80.9 | 54.4 |
| Net income | 494 | 493 | 593 | 586 | 662 | 346 | 242 | 207 | 151 | 144 |
| Net income to common shareholders | 494 | 493 | 593 | 586 | 662 | 346 | 242 | 207 | 151 | 144 |
| Basic EPS | 6.83 | 6.75 | 7.98 | 7.87 | 8.89 | 4.68 | 3.27 | 2.80 | 2.04 | 1.96 |
| Diluted EPS | 6.79 | 6.69 | 7.88 | 7.73 | 8.67 | 4.57 | 3.21 | 2.74 | 1.99 | 1.91 |
| Average shares (basic) | 72.3 | 73.0 | 74.3 | 74.4 | 74.4 | 73.9 | 74.0 | 73.9 | 73.9 | 73.3 |
| Average shares (diluted) | 72.7 | 73.7 | 75.3 | 75.8 | 76.3 | 75.8 | 75.4 | 75.4 | 75.8 | 75.0 |
| Dividend per share | 0.85 | 0.81 | 0.77 | 0.73 | 0.69 | 0.65 | 0.61 | 0.57 | 0.53 | 0.49 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 875 | 872 | 845 | 805 | 805 | 767 | 698 | 749 | 747 | 702 | 695 | 732 |
| Cost of revenue | 527 | 543 | 549 | 501 | 510 | 493 | 466 | 475 | 482 | 472 | 465 | 454 |
| Gross profit | 347 | 329 | 296 | 304 | 294 | 274 | 232 | 274 | 265 | 230 | 230 | 278 |
| Selling, general and administrative | 109 | 112 | 99.5 | 108 | 101 | 94.5 | 86.6 | 83.3 | 81.9 | 83.0 | 86.7 | 90.7 |
| Research and development | 18.3 | 19.7 | 15.8 | 21.8 | 17.1 | 19.1 | 16.3 | 18.5 | 15.5 | 17.5 | 17.6 | 18.4 |
| Operating income | 222 | 196 | 183 | 174 | 176 | 160 | 129 | 172 | 167 | 130 | 126 | 168 |
| EBIT | 222 | 196 | 183 | 174 | 176 | 160 | 129 | 172 | 167 | 130 | 126 | 168 |
| EBITDA | 268 | 242 | 229 | 221 | 219 | 201 | 169 | 213 | 207 | 168 | 161 | 204 |
| Interest expense | 3.8 | 2.6 | 1.9 | -0.2 | 0.2 | 0.1 | 0.4 | — | 0.7 | 1.5 | 1.6 | 1.2 |
| Pre-tax income | 272 | 186 | 184 | 165 | 174 | 162 | 114 | 167 | 168 | 133 | 132 | 172 |
| Income tax | 58.0 | 32.2 | 44.7 | 33.3 | 34.0 | 30.2 | 24.1 | 36.8 | 32.4 | 21.9 | 16.4 | 34.5 |
| Net income | 214 | 154 | 139 | 132 | 140 | 132 | 89.8 | 130 | 136 | 111 | 115 | 137 |
| Net income to common shareholders | 214 | 154 | 139 | 132 | 140 | 132 | 89.8 | 130 | 136 | 111 | 115 | 137 |
| Basic EPS | 3.04 | 2.18 | 1.93 | 1.83 | 1.94 | 1.83 | 1.24 | 1.79 | 1.87 | 1.52 | 1.57 | 1.85 |
| Diluted EPS | 3.02 | 2.15 | 1.92 | 1.82 | 1.92 | 1.82 | 1.23 | 1.78 | 1.85 | 1.51 | 1.55 | 1.82 |
| Average shares (basic) | 70.4 | 70.8 | 72.0 | 72.3 | 72.2 | 72.2 | 72.5 | 72.7 | 72.8 | 73.0 | 73.5 | 74.1 |
| Average shares (diluted) | 70.8 | 71.3 | 72.4 | 72.7 | 72.6 | 72.5 | 73.0 | 73.3 | 73.4 | 73.7 | 74.3 | 75.0 |
| Dividend per share | 0.22 | 0.22 | 0.22 | 0.22 | 0.21 | 0.21 | 0.21 | 0.21 | 0.20 | 0.20 | 0.20 | 0.20 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4,270 | 3,643 | 3,830 | 3,617 | 3,314 | 2,794 | 2,341 | 1,979 | 1,863 | 1,717 |
| Current assets | 1,978 | 1,538 | 1,936 | 1,920 | 1,742 | 1,374 | 1,059 | 894 | 744 | 642 |
| Cash and equivalents | 791 | 485 | 854 | 894 | 763 | 616 | 439 | 337 | 236 | 203 |
| Receivables | 586 | 576 | 534 | 524 | 504 | 385 | 319 | 288 | 253 | 201 |
| Inventory | 444 | 377 | 435 | 415 | 378 | 321 | 236 | 215 | 215 | 199 |
| Net property, plant and equipment | 1,878 | 1,716 | 1,513 | 1,263 | 1,127 | 1,012 | 909 | 822 | 855 | 778 |
| Goodwill | 110 | 106 | 109 | 107 | 110 | 111 | 108 | 106 | 108 | 103 |
| Other intangible assets | 7.7 | 10.8 | 15.1 | 18.4 | 23.0 | 30.5 | 29.8 | 20.3 | 21.7 | 23.3 |
| Long-term investments | 212 | 202 | 210 | 205 | 208 | 215 | 193 | 91.2 | 85.8 | 82.7 |
| Current liabilities | 655 | 550 | 672 | 519 | 594 | 503 | 342 | 284 | 280 | 241 |
| Accounts payable | 254 | 239 | 242 | 215 | 232 | 213 | 157 | 130 | 138 | 122 |
| Long-term debt | 203 | 203 | 207 | 209 | 253 | 255 | 255 | 196 | 197 | 229 |
| Total debt | 326 | 305 | 309 | 318 | 325 | 331 | 331 | 196 | 197 | 229 |
| Total liabilities | 1,094 | 961 | 949 | 932 | 978 | 939 | 768 | 583 | 583 | 599 |
| Total equity (incl. minority) | 3,176 | 2,682 | 2,881 | 2,685 | 2,335 | 1,855 | 1,573 | 1,396 | 1,280 | 1,118 |
| Retained earnings | 4,375 | 3,957 | 3,523 | 2,988 | 2,457 | 1,847 | 1,549 | 1,353 | 1,178 | 1,072 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4,061 | 4,076 | 4,110 | 4,270 | 4,106 | 3,953 | 3,618 | 3,643 | 3,675 | 3,489 | 3,602 | 3,830 |
| Current assets | 1,817 | 1,808 | 1,827 | 1,978 | 1,823 | 1,681 | 1,458 | 1,538 | 1,551 | 1,483 | 1,693 | 1,936 |
| Cash and equivalents | 464 | 436 | 521 | 791 | 629 | 510 | 404 | 485 | 491 | 446 | 602 | 854 |
| Receivables | 763 | 729 | 701 | 586 | 653 | 610 | 569 | 576 | 567 | 502 | 544 | 534 |
| Inventory | 465 | 447 | 453 | 444 | 438 | 421 | 389 | 377 | 401 | 419 | 430 | 435 |
| Net property, plant and equipment | 1,808 | 1,824 | 1,846 | 1,878 | 1,874 | 1,861 | 1,767 | 1,716 | 1,711 | 1,635 | 1,545 | 1,513 |
| Goodwill | 109 | 109 | 109 | 110 | 111 | 111 | 108 | 106 | 109 | 107 | 108 | 109 |
| Other intangible assets | 6.2 | 6.4 | 7.0 | 7.7 | 8.9 | 9.7 | 10.0 | 10.8 | 12.3 | 12.9 | 13.9 | 15.1 |
| Long-term investments | 216 | 208 | 209 | 212 | 221 | 225 | 212 | 202 | 218 | 198 | 203 | 210 |
| Current liabilities | 644 | 641 | 674 | 655 | 635 | 605 | 527 | 550 | 517 | 634 | 648 | 672 |
| Accounts payable | 249 | 253 | 252 | 254 | 256 | 239 | 228 | 239 | 224 | 212 | 240 | 242 |
| Long-term debt | 203 | 203 | 203 | 203 | 203 | 203 | 203 | 203 | 203 | 72.9 | 72.8 | 72.8 |
| Total debt | 314 | 317 | 321 | 326 | 303 | 308 | 307 | 305 | 308 | 314 | 307 | — |
| Total liabilities | 1,093 | 1,086 | 1,119 | 1,094 | 1,054 | 1,024 | 935 | 961 | 923 | 913 | 922 | 949 |
| Total equity (incl. minority) | 2,968 | 2,990 | 2,990 | 3,176 | 3,052 | 2,929 | 2,683 | 2,682 | 2,752 | 2,577 | 2,681 | 2,881 |
| Retained earnings | 4,817 | 4,624 | 4,476 | 4,375 | 4,262 | 4,139 | 4,031 | 3,957 | 3,857 | 3,721 | 3,624 | 3,523 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 755 | 653 | 777 | 724 | 584 | 473 | 367 | 289 | 263 | 219 |
| Depreciation and amortization | 171 | 155 | 137 | 121 | 122 | 109 | 103 | 104 | 96.7 | 90.7 |
| Capital expenditure | -286 | -377 | -362 | -285 | -253 | -174 | -126 | -105 | -131 | -170 |
| Investing cash flow | -286 | -379 | -369 | -288 | -253 | -180 | -228 | -101 | -134 | -176 |
| Financing cash flow | -185 | -623 | -460 | -294 | -168 | -137 | -36.8 | -80.7 | -109 | -114 |
| Dividends paid | -61.2 | -59.1 | -57.0 | -54.1 | -51.1 | -48.1 | -45.1 | -42.1 | -39.1 | -35.8 |
| Share repurchases | -134 | -561 | -438 | -203 | -137 | -116 | -83.1 | -70.8 | -74.4 | -52.2 |
| Debt issued | 0.0 | 165 | 0.0 | 0.0 | — | — | 199 | — | — | — |
| Debt repaid | -1.1 | -192 | -2.4 | -44.3 | -2.2 | -2.3 | -136 | -0.1 | -34.9 | -69.8 |
| Effect of exchange rates | 22.9 | -21.4 | 11.4 | -10.5 | -15.7 | 20.5 | -0.7 | -5.6 | 12.2 | -1.3 |
| Net change in cash | 307 | -369 | -40.4 | 132 | 147 | 176 | 102 | 102 | 32.9 | -71.6 |
| Free cash flow | 469 | 276 | 415 | 439 | 331 | — | — | — | — | — |
| Levered free cash flow | 274 | 207 | 196 | 247 | 210 | 250 | 165 | 121 | 98.8 | 32.0 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 190 | 124 | 89.9 | 251 | 197 | 177 | 129 | 190 | 180 | 165 | 118 | 239 |
| Depreciation and amortization | 45.9 | 46.2 | 45.2 | 47.0 | 43.0 | 41.4 | 40.0 | 40.7 | 40.2 | 38.9 | 35.6 | 35.9 |
| Capital expenditure | -39.1 | -43.2 | -42.7 | -76.1 | -63.3 | -75.2 | -71.3 | -105 | -81.3 | -100 | -90.6 | -109 |
| Investing cash flow | 78.9 | -43.2 | -42.7 | -76.1 | -63.3 | -75.2 | -71.3 | -105 | -82.1 | -101 | -90.6 | -109 |
| Financing cash flow | -242 | -165 | -309 | -11.7 | -11.5 | -14.9 | -147 | -68.9 | -64.4 | -218 | -271 | -190 |
| Dividends paid | -15.5 | -15.7 | -15.8 | -15.8 | -15.1 | -15.1 | -15.2 | -15.3 | -14.5 | -14.6 | -14.7 | -14.8 |
| Share repurchases | -232 | -157 | -300 | -0.2 | -0.1 | -0.5 | -136 | -54.6 | -52.4 | -187 | -272 | -177 |
| Debt issued | 0.0 | 50.0 | — | 0.0 | 0.0 | — | — | 0.0 | 130 | 35.0 | — | — |
| Debt repaid | -0.5 | -50.4 | -0.3 | -0.3 | -0.3 | -0.3 | -0.2 | -0.1 | -133 | -58.3 | -0.7 | -0.7 |
| Effect of exchange rates | 1.7 | -1.6 | -8.4 | -0.5 | -3.6 | 18.5 | 8.5 | -22.7 | 11.1 | -1.1 | -8.7 | 14.5 |
| Net change in cash | 28.3 | -85.6 | -270 | 163 | 119 | 106 | -80.4 | -6.3 | 44.7 | -156 | -252 | -44.7 |
| Free cash flow | 150 | 80.8 | 47.2 | 175 | 134 | 102 | 58.1 | 85.2 | 98.8 | 64.8 | 27.6 | 130 |
| Levered free cash flow | 172 | 35.6 | 24.4 | 113 | 104 | 34.2 | 22.6 | 89.6 | 61.0 | 59.9 | -4.2 | 82.4 |
Financial statements of similar companies
Companies in the group: same industry, similar size
